Hard‑Tech Firms Drive Hong Kong IPO Boom as “A+H” Listings Gain Momentum
Hong Kong’s IPO market has maintained strong momentum in 2026, with 51 companies already listed by May 12 and total financing exceeding HKD 150 billion, a sharp increase from last year. Hard‑tech enterprises have emerged as the main force, while the “A+H” dual‑listing model is gaining traction. Global sovereign wealth funds and long‑term investors are participating deeply, reinforcing Hong Kong’s role as a hub for Chinese innovation capital.
Reforms at HKEX have lowered thresholds for tech and biotech firms, streamlined approval processes, and introduced confidential filings and fast reviews. These measures have shortened listing cycles, reduced costs, and attracted quality A‑share companies to pursue Hong Kong listings. The IPO pipeline is increasingly dominated by technology, AI, and advanced manufacturing, with large‑cap projects accounting for most new listings. Analysts note that 77% of IPOs since 2026 have had market values above HKD 10 billion, reflecting improved project quality.
International capital has responded strongly. Cornerstone investment has surged, with UBS, Abu Dhabi Investment Authority, and Qatar Investment Authority among those backing new issues. This reflects renewed confidence in the allocation value of Chinese assets. Goldman Sachs estimates Hong Kong’s equity supply this year will reach USD 110 billion, supported by dividends, buybacks, southbound inflows, and global reallocations.
The “A+H” model has become a key driver of IPO financing. Industry leaders such as Muyuan Foods, Dongpeng Beverage, and GigaDevice are pursuing dual listings, leveraging both domestic and overseas markets. Analysts say this structure reduces costs, enhances global financing capacity, and strengthens brand and valuation. More than 100 A‑share firms are in the queue, underscoring the model’s appeal. At the same time, Hong Kong firms are actively “returning to A” to seek better valuations and liquidity, supported by clear policy pathways.
Authorities are preparing further reforms to consolidate Hong Kong’s capital‑market position. Expected measures include expanding confidential filing, easing restrictions on dual‑class shares, optimizing IPO allocation and pricing, and moving settlement toward T+1. These changes will open financing doors for smaller, pre‑profit hard‑tech firms in AI, semiconductors, and biotech, while strengthening founder control and creating a healthy balance between large projects that provide stability and smaller projects that add volume. Regulators are also tightening oversight to improve IPO quality, warning against weaker applications and raising standards from the source.
Hong Kong’s IPO market is thus moving toward a dual trajectory of rising volume and quality. Market heat and regulatory intensity are increasing together, reinforcing Hong Kong’s role as a global capital hub. Professional service providers in law, finance, marketing, and testing are gathering to support companies from the mainland and beyond in their globalization strategies. With sovereign wealth funds and long‑term capital acting as stabilizers, and with reforms continuing to deepen, Hong Kong is positioned to remain the core platform for Chinese hard‑tech firms going global and for international investors seeking exposure to innovation.











